NEWS

  Glad to announce that Tricopharming has been selected among the 20 most innovative tech startups of Catalonia Region within the framework of the Startup Capital 2019 call! Startup Capital boosts early stage technological companies helping to accelerate their product development and road map to market by co-financing business plan implementation.  The call is addressed…

Luis Matías, through his company Biotech Tricopharming Research, wants to study the antiviral properties of his product derived from Artemisia annua with the new coronavirus

Artemisia annua plant contains more than 400 metabolites. Among them, stands out the molecule artemisinin, the most effective antimalarial treatment to date. Could Artemisia annua and/or artemisinin molecule be a good candidate to fight Covid-19? This TV news contributes to the debate with our CEO Luís Matías Hernández, PhD, and our Agricultural Engineer Andrés Acosta Pérez by Biotech Tricopharming Research.…

Validation of a biostimulation technology able to increase molecules´ and secondary metabolites concentration both in Artemisia annua plant and other Medicinal and Aromatic Plants. The project also pretends to test and validate the therapeutic and functional potential of Artennua® extract. The Centre for the Technological and Industrial Development (CDTI) by Government of Spain, approved our project proposal ‘Validation of a…